Back to BlackRock, Inc. BlackRock, Inc.

CBIOCBIO
5 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CRESCENT BIOPHARMA INC.

BlackRock, Inc. holds 1.3M shares of CBIO (CRESCENT BIOPHARMA INC.), worth $22.9M as of 2026-Q2. The position was increased (+999.0% shares). CBIO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$22.9M

Current Shares

1.3M

Total Value Change

+$22.8M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+999.0%
$22.9M0.0%$18.00
46
2026-Q1
Increased
115,725
+6.0%
$2.1M0.0%$11.19
19
2025-Q4
Increased
109,230
+0.1%
$1.3M0.0%$11.60
17
2025-Q3
Increased
109,115
+1703.3%
$1.3M0.0%$12.29
28
2025-Q2
New
6,051
-
$97,6630.0%$15.90
33

Other major holders of CBIO: FMR LLC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used